Director, Global Medical Affairs Strategy - Solid Tumors

Director, Global Medical Affairs Strategy – Solid Tumors

Join to apply for the Director, Global Medical Affairs Strategy – Solid Tumors role at Genmab.

At Genmab, we are dedicated to building extraordinary® futures by developing antibody products and groundbreaking KYSO antibody medicines® that change lives and the future of cancer treatment. We strive to create a global workplace where individuals’ unique contributions are valued and drive innovative solutions.

The Role

The Genmab pipeline comprises robust and diverse antibody products in immuno‑oncology and beyond. Reporting to the Global Medical Affairs Strategy Lead (MASL), the Director will be responsible for the development and execution of the Global Medical Affairs strategic and tactical plans for the asset(s), focusing on the primary indication and new indications to expand into as part of the asset life‑cycle management.

The Director should have a strong background in the field of solid tumors, with proven ability to translate and align commercial and scientific goals into actions. The position is an integral part of the Medical Affairs Strategy Team, working closely with the MASL and cross‑functional medical affairs partners to provide strategic direction for the program. The Director will also support data generation, life‑cycle management initiatives, and establish and maintain relationships with global thought leaders.

Job Responsibilities

• Lead annual medical planning for asset(s); work closely with extended medical affairs functions (global and regional markets) to inform and implement overall medical strategy for designated products and therapeutic areas.

• Lead and execute engagement strategy with thought leaders, patient advocacy groups, professional societies and institutions.

• Lead the planning and execution of Early Access Program, investigator‑initiated trials program, and other initiatives, ensuring compliance, quality, timeliness and budget alignment with MASL.

• Contribute to and execute on the life‑cycle management of the asset(s).

• Drive collaboration with cross‑functional teams (e.g., commercial, field/regional, medical information/communication, HEOR) to provide support, medical review, and medical expertise as required.

• Collaborate with medical and clinical operations departments to coordinate the planning, execution and management of clinical trial activities across medical affairs functions.

• Contribute to effective publication planning to ensure consistent and meaningful scientific communication.

• Contribute to the development of internal guidance and process/resource documents.

• Contribute to development and review of regulatory documents for regulatory submissions.

• Serve as medical reviewer and expert on promotional and medical review committees.

• Inform development of strategies to demonstrate the value of disease/products with focus on payer and clinical decision‑maker outcomes.

• Lead the strategy team congress activity planning in collaboration with cross‑functional stakeholders, and compile congress reports including key competitive intelligence.

• Lead and collaborate on cross‑functional launch activities globally.

Requirements

• Scientific or Medical Degree (Pharm D, PhD, MD) required.

• Expertise in the clinical landscape of solid tumors required; knowledge of gynecological cancers preferred.

• 7+ years of medical affairs or clinical development background in oncology.

• Biotech / Pharmaceutical industry experience, with a strong understanding of solid tumor drug development and medical affairs function.

• Ability to work successfully under pressure in a fast‑paced environment with tight timelines.

• Demonstrated ability to lead strategically, drive performance, build alignment, and negotiate across partnerships.

• Ability to lead collaboratively across various internal stakeholders and develop trusted partnerships.

• Strong ability to interpret and articulate clinical/HEOR data and its impact on development programs.

• In‑depth understanding of compliance and regulatory requirements for pharmaceutical medical affairs, R&D and commercial work.

• Knowledge of evidence‑based medicine concepts, applied…